Corvus Pharmaceuticals
CRVS
#8096
Rank
โ‚ฌ0.18 B
Marketcap
2,72ย โ‚ฌ
Share price
-6.85%
Change (1 day)
68.59%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2024 (TTM): -โ‚ฌ56.9 Million

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -โ‚ฌ24.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ56.72 Million130.47%
2023 -โ‚ฌ24.61 Million-34.57%
2022 -โ‚ฌ37.61 Million-4.47%
2021 -โ‚ฌ39.37 Million621.28%
2020 -โ‚ฌ5.46 Million-87.16%
2019 -โ‚ฌ42.5 Million-0.57%
2018 -โ‚ฌ42.74 Million-15.67%
2017 -โ‚ฌ50.68 Million53.03%
2016 -โ‚ฌ33.12 Million16.08%
2015 -โ‚ฌ28.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.14 Billion 129.39%๐Ÿ‡บ๐Ÿ‡ธ USA